VNDA
Vanda Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
5.09 / 10
Netural
Fund flow is robust (7.64/10) with positive overall and extra-large block trends, hinting at underlying buying interest. Analyst sentiment is split: 66.7% Strong Buy and 33.3% Neutral, yet historical win rates are only moderate (50%). This blend of strong money flow and mixed analyst views supports a neutral stance with attention to upcoming catalysts.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
67%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-12-31
InstitutionJefferies
Times predicted1
Historical Win Rate0.0%
What is the analyst consensus for VNDA?
- VNDA holds a Bearish analyst rating, with 67% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.09/10 (Netural).
